These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31235278)

  • 1. Oncolytic Measles Virotherapy and Opposition to Measles Vaccination.
    Russell SJ; Babovic-Vuksanovic D; Bexon A; Cattaneo R; Dingli D; Dispenzieri A; Deyle DR; Federspiel MJ; Fielding A; Galanis E; Lacy MQ; Leibovich BC; Liu MC; Muñoz-Alía M; Miest TC; Molina JR; Mueller S; Okuno SH; Packiriswamy N; Peikert T; Raffel C; Van Rhee F; Ungerechts G; Young PR; Zhou Y; Peng KW
    Mayo Clin Proc; 2019 Sep; 94(9):1834-1839. PubMed ID: 31235278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles virus.
    Naim HY
    Hum Vaccin Immunother; 2015; 11(1):21-6. PubMed ID: 25483511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spotlight on measles in Italy: why outbreaks of a vaccine-preventable infection continue in the 21st century.
    Piccirilli G; Lazzarotto T; Chiereghin A; Serra L; Gabrielli L; Lanari M
    Expert Rev Anti Infect Ther; 2015 Mar; 13(3):355-62. PubMed ID: 25612664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles: eliminated but not eradicated.
    Alspach JG
    Crit Care Nurse; 2015 Jun; 35(3):10-4. PubMed ID: 26033097
    [No Abstract]   [Full Text] [Related]  

  • 5. Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination.
    Baldo A; Galanis E; Tangy F; Herman P
    Hum Vaccin Immunother; 2016 May; 12(5):1102-16. PubMed ID: 26631840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMR immunisation after contact with measles virus.
    Rice P; Young Y; Cohen B; Ramsay M
    Lancet; 2004 Feb; 363(9408):569-70. PubMed ID: 14975626
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States.
    Lo NC; Hotez PJ
    JAMA Pediatr; 2017 Sep; 171(9):887-892. PubMed ID: 28738137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles virus as an oncolytic vector platform.
    Blechacz B; Russell SJ
    Curr Gene Ther; 2008 Jun; 8(3):162-75. PubMed ID: 18537591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles vaccine: immunity, reinfection and revaccination.
    Linnemann CC
    Am J Epidemiol; 1973 Jun; 97(6):365-71. PubMed ID: 4713932
    [No Abstract]   [Full Text] [Related]  

  • 12. Measles lessons in an anti-vaccination era: public health is a social duty, not a political option.
    Lancella L; Di Camillo C; Vittucci AC; Boccuzzi E; Bozzola E; Villani A
    Ital J Pediatr; 2017 Nov; 43(1):102. PubMed ID: 29141656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The return of measles to Europe highlights the need to regain confidence in immunisation.
    Dotevall L
    Acta Paediatr; 2019 Jan; 108(1):8-9. PubMed ID: 30412928
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunologic response and post-vaccination reactions in children vaccinated against measles. I. Assessment of post-vaccination reactions].
    Naruszewicz-Lesiuk D; Kańtoch M; Polna I
    Przegl Epidemiol; 1974; 28(3):315-24. PubMed ID: 4471837
    [No Abstract]   [Full Text] [Related]  

  • 15. Measles vaccination coverage and seroprevalence of anti-measles antibody in south-east Islamic Republic of Iran.
    Izadi S; Mokhtari-Azad T; Zahraei SM
    East Mediterr Health J; 2015 Sep; 21(6):396-402. PubMed ID: 26369998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia).
    Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE
    J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The declining antibody level of measles virus in China population, 2009-2015.
    Hu Y; Lu P; Deng X; Guo H; Zhou M
    BMC Public Health; 2018 Jul; 18(1):906. PubMed ID: 30041607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles outbreak in a community with very low vaccine coverage, the Netherlands.
    van den Hof S; Meffre CM; Conyn-van Spaendonck MA; Woonink F; de Melker HE; van Binnendijk RS
    Emerg Infect Dis; 2001; 7(3 Suppl):593-7. PubMed ID: 11485681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles.
    Elliman D; Sengupta N
    Curr Opin Infect Dis; 2005 Jun; 18(3):229-34. PubMed ID: 15864100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.